Ensayos clínicos

Search for actively enrolling clinical trials

AALL1621: A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518, IND#133494) in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)

Study ID: STU 062017-028

Cancer Related
Healthy Volunteers
No
UT Southwestern Principal Investigator
Tamra Lynn Slone

Contact:

Anil Shalwani

Anil.Shalwani@childrens.com

Linked In Email
scroll to top
Powered by Translations.com GlobalLink Web Software